The historical rank and industry rank for Agios Pharmaceuticals's Days Inventory or its related term are showing as below:
AGIO'
s Days Inventory Range Over the Past 10 Years
Min: 227.05 Med: 1782.66 Max: 2063.15
Current: 2063.15
During the past 13 years, Agios Pharmaceuticals's highest Days Inventory was 2063.15. The lowest was 227.05. And the median was 1782.66.
AGIO's Days Inventory is ranked worse than 96.11% of 642
companies
in the Biotechnology industry
Industry Median: 179.595
vs AGIO: 2063.15
Agios Pharmaceuticals's Days Inventory
declined
from Mar. 2024 (3,066.84) to Mar. 2025 (2,406.18).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Agios Pharmaceuticals's Inventory Turnover for the
three
months ended in Mar. 2025 was 0.04.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Agios Pharmaceuticals's Inventory-to-Revenue for the
three
months ended in Mar. 2025 was 3.28.
Agios Pharmaceuticals Days Inventory Historical Data
The historical data trend for Agios Pharmaceuticals's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Agios Pharmaceuticals's Days Inventory
For the Biotechnology subindustry, Agios Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Agios Pharmaceuticals's Days Inventory Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Agios Pharmaceuticals's Days Inventory distribution charts can be found below:
* The bar in red indicates where Agios Pharmaceuticals's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Agios Pharmaceuticals (NAS:AGIO) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Agios Pharmaceuticals's Inventory Turnover for the
three
months ended in Mar. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Agios Pharmaceuticals's Inventory to Revenue for the
three
months ended in Mar. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Agios Pharmaceuticals Days Inventory Related Terms
Thank you for viewing the detailed overview of Agios Pharmaceuticals's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AGIO has been successfully added to your 